FDA Inspection 1221700 — Cedars-Sinai Medical Center IRB
The FDA completed an inspection of Cedars-Sinai Medical Center IRB on September 28, 2023 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 28, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Los Angeles, CA (United States)
Additional Details
IRB